Noninvasive transcranial focal stimulation via tripolar concentric ring electrodes lessens behavioral seizure activity of recurrent pentylenetetrazole administrations in rats.
Epilepsy affects approximately 1% of the world population. Antiepileptic drugs are ineffective in approximately 30% of patients and have side effects. We have been developing a noninvasive transcranial focal electrical stimulation with our novel tripolar concentric ring electrodes as an alternative/complementary therapy for seizure control. In this study we demonstrate the effect of focal stimulation on behavioral seizure activity induced by two successive pentylenetetrazole administrations in rats. Seizure onset latency, time of the first behavioral change, duration of seizure, and maximal seizure severity score were studied and compared for focal stimulation treated (n = 9) and control groups (n = 10). First, we demonstrate that no significant difference was found in behavioral activity for focal stimulation treated and control groups after the first pentylenetetrazole administration. Next, comparing first and second pentylenetetrazole administrations, we demonstrate there was a significant change in behavioral activity (time of the first behavioral change) in both groups that was not related to focal stimulation. Finally, we demonstrate focal stimulation provoking a significant change in seizure onset latency, duration of seizure, and maximal seizure severity score. We believe that these results, combined with our previous reports, suggest that transcranial focal stimulation may have an anticonvulsant effect.
Department of Electrical, Computer, and Biomedical Engineering, University of Rhode Island, Kingston, RI 02881 USA. omakeyev@ele.uri.edu
Oleksandr
O
Makeyev
Hiram
H
Luna-Munguía
Gabriela
G
Rogel-Salazar
Xiang
X
Liu
Walter G
WG
Besio
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004566:Electrodes; D004867:Equipment Design; D019544:Equipment Failure Analysis; D008297:Male; D010433:Pentylenetetrazole / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology* / Q000517:prevention & control*; D050781:Transcranial Magnetic Stimulation / Q000295:instrumentation* / Q000379:methods*; D016896:Treatment Outcome
D010433:Pentylenetetrazole